Endometrial appearances in postmenopausal tamoxifen-used breast cancer patients
Not Applicable
- Conditions
- breast cancer with tamoxifen usedendometrial pathology,endometrial thickening,breast cancer,postmenopause,tamoxifen
- Registration Number
- TCTR20170630001
- Lead Sponsor
- /A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
postmenopausal tamoxifen-used breast cancer patients,
age over 50 year who treated and follow up at Phramongkutklao hospital
Exclusion Criteria
breast cancer who used other hormonal treatment or used any steroid product with in 6 months
breast cancer who had diagnosed about endometrial abnormalities before recruitment or had history of pelvic radiation
breast cancer who have contraindication to endometrial sampling
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method endometrial appearance at the day of recruitment endometial sampling
- Secondary Outcome Measures
Name Time Method endometrial thickening at the day of recruitment transvaginal ultrasound